advertisement
11.9 Gene therapy (21)
Showing records 1 to 21
Display all abstracts in classification 11.9 Gene therapy
Search within classification 11.9 Gene therapy66631 Adeno-associated virus mediated SOD gene therapy protects the retinal ganglion cells from chronic intraocular pressure elevation induced injury via attenuating oxidative stress and improving mitochondrial dysfunction in a rat model
Jiang W
American journal of translational research 2016; 8: 799-810
67471 Gene transfer to the outflow tract
Dang Y
Experimental Eye Research 2017; 158: 73-84
66792 Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress
Hines-Beard J
Journal of Neuroinflammation 2016; 13: 39
67591 Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Boyd RF
Gene Therapy 2016; 23: 548-556
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Borrás T
Gene Therapy 2016; 23: 438-449
67591 Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Boye SL
Gene Therapy 2016; 23: 548-556
66792 Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress
Bond WS
Journal of Neuroinflammation 2016; 13: 39
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Buie LK
Gene Therapy 2016; 23: 438-449
66631 Adeno-associated virus mediated SOD gene therapy protects the retinal ganglion cells from chronic intraocular pressure elevation induced injury via attenuating oxidative stress and improving mitochondrial dysfunction in a rat model
Tang L
American journal of translational research 2016; 8: 799-810
67471 Gene transfer to the outflow tract
Loewen R
Experimental Eye Research 2017; 158: 73-84
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Spiga MG
Gene Therapy 2016; 23: 438-449
66631 Adeno-associated virus mediated SOD gene therapy protects the retinal ganglion cells from chronic intraocular pressure elevation induced injury via attenuating oxidative stress and improving mitochondrial dysfunction in a rat model
Zeng J
American journal of translational research 2016; 8: 799-810
67591 Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Conlon TJ
Gene Therapy 2016; 23: 548-556
67471 Gene transfer to the outflow tract
Parikh HA
Experimental Eye Research 2017; 158: 73-84
66792 Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress
Backstrom JR
Journal of Neuroinflammation 2016; 13: 39
66631 Adeno-associated virus mediated SOD gene therapy protects the retinal ganglion cells from chronic intraocular pressure elevation induced injury via attenuating oxidative stress and improving mitochondrial dysfunction in a rat model
Chen B
American journal of translational research 2016; 8: 799-810
67591 Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Erger KE
Gene Therapy 2016; 23: 548-556
67471 Gene transfer to the outflow tract
Roy P
Experimental Eye Research 2017; 158: 73-84
66792 Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress
Rex TS
Journal of Neuroinflammation 2016; 13: 39
67471 Gene transfer to the outflow tract
Loewen NA
Experimental Eye Research 2017; 158: 73-84
67591 Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Sledge DG; Langohr IM; Hauswirth WW; Komáromy AM; Boye SE; Petersen-Jones SM; Bartoe JT
Gene Therapy 2016; 23: 548-556
